Effect of cytokine modulation by thalidomide on the granulomatous response in murine tuberculosis.

[1]  G. Kaplan,et al.  Thalidomide and thalidomide analogs reduce HIV type 1 replication in human macrophages in vitro. , 1997, AIDS research and human retroviruses.

[2]  D. Russell,et al.  IL-6 produced by macrophages infected with Mycobacterium species suppresses T cell responses. , 1997, Journal of immunology.

[3]  G. Kaplan,et al.  Sequestration of Mycobacterium tuberculosis in tight vacuoles in vivo in lung macrophages of mice infected by the respiratory route , 1997, Infection and immunity.

[4]  G. Kaplan,et al.  Perforin, a cytotoxic molecule which mediates cell necrosis, is not required for the early control of mycobacterial infection in mice , 1997, Infection and immunity.

[5]  David Baltimore,et al.  An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death , 1996, Science.

[6]  Marty W. Mayo,et al.  TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB , 1996, Science.

[7]  Seamus J. Martin,et al.  Suppression of TNF-α-Induced Apoptosis by NF-κB , 1996, Science.

[8]  Gilla Kaplan,et al.  Selection of Novel Analogs of Thalidomide with Enhanced Tumor Necrosis Factor α Inhibitory Activity , 1996, Molecular medicine.

[9]  P. Linsley,et al.  Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression , 1996, Infection and immunity.

[10]  R. North,et al.  Virulence ranking of some Mycobacterium tuberculosis and Mycobacterium bovis strains according to their ability to multiply in the lungs, induce lung pathology, and cause mortality in mice , 1995, Infection and immunity.

[11]  C. Lowenstein,et al.  Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. , 1995, Immunity.

[12]  W. Rom,et al.  Thalidomide Treatment Reduces Tumor Necrosis Factor α Production and Enhances Weight Gain in Patients with Pulmonary Tuberculosis , 1995, Molecular medicine.

[13]  Hans-Dieter Volk,et al.  Up-regulation of monocytic IL-10 by tumor necrosis factor-α and cAMP elevating drugs , 1995 .

[14]  J. Kolls,et al.  Exacerbation of acute and chronic murine tuberculosis by administration of a tumor necrosis factor receptor-expressing adenovirus. , 1995, The Journal of infectious diseases.

[15]  G. Kaplan,et al.  Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guerin , 1994, The Journal of experimental medicine.

[16]  J. Flynn,et al.  An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection , 1993, The Journal of experimental medicine.

[17]  G. Kaplan,et al.  The influence of thalidomide on the clinical and immunologic manifestation of erythema nodosum leprosum. , 1993, The Journal of infectious diseases.

[18]  G. Kaplan,et al.  Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation , 1993, The Journal of experimental medicine.

[19]  G. Kaplan,et al.  Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes , 1991, The Journal of experimental medicine.

[20]  P. Brennan,et al.  Local production of tumor necrosis factor and IFN-gamma in tuberculous pleuritis. , 1990, Journal of immunology.

[21]  W. Bursch,et al.  Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats. , 1990, Carcinogenesis.

[22]  K. Tracey,et al.  Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia , 1989, The Journal of experimental medicine.

[23]  V. Kindler,et al.  The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection , 1989, Cell.

[24]  K. Stýblo,et al.  Overview and epidemiologic assessment of the current global tuberculosis situation with an emphasis on control in developing countries. , 1989, Reviews of infectious diseases.

[25]  J. Pober.  Warner-Lambert/Parke-Davis award lecture. Cytokine-mediated activation of vascular endothelium. Physiology and pathology. , 1988, The American journal of pathology.

[26]  K. Tracey,et al.  Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation , 1988, The Journal of experimental medicine.

[27]  A. Vladutiu,et al.  The immuno-suppressive effect of thalidomide in experimental tuberculosis in guinea-pigs. , 1967, Tubercle.

[28]  I. Orme,et al.  Materials and Methods Briefdefinitive Report Disseminated Tuberculosis in Interferon 7 Gene-disrupted Mice , 2022 .